Morgan Lewis

FDA & Healthcare

For More Information

Read the Brochure

Read the FDA and Healthcare Practice brochure.

Fast Facts

LMG Life Sciences 2012 – Recommended for FDA – Pharmaceuticals and Healthcare: Pricing and Reimbursement

PLCCross-border Quarterly 2012 Life Sciences Legal Market Review

  • Industry Super League - Ranked 14th among law firms worldwide
  • Regulatory Super League - Ranked 8th among law firms worldwide

PLCCross-border Life Sciences Handbook 2007/2008

  • U.S. - Recognized for commercial/ partnering, competition/ antitrust, corporate, government law enforcement/ investigations, regulatory, regulatory/ medical devices, and patent counseling
  • England - Recognized for regulatory
  • Japan - Recognized for corporate/commercial

Chambers USA 2012: Washington, D.C. for healthcare/ pharmaceutical/medical products regulatory – Band 3

UK Legal 500 2007/2008: London: Pharmaceuticals and Biotechnology

New Resource

Healthcare Policy and Reform Resource Center

Related Events

06/12/13-06/15/13 2013 American Orthopaedic Association (AOA) Annual Leadership Meeting Denver, CO
Katie McDermott, presenter, "Off-Label Device Use: Acting in the Best Interest of Your Patient"
06/19/13-06/20/13 Rx Drug Pricing Boot Camp
Stephen Ruscus, speaker
View all events

Related Publications

05/15/13 Raising the Stakes of Worker Misclassification Yet Again
New requirements under the Patient Protection and Affordable Care Act are set to intensify state and federal governments' crackdown on worker misclassification.
05/10/13 OIG Revises Special Advisory Bulletin on Exclusions
OIG continues its aggressive interpretation of scope and effect of exclusion from participation in Federal health care programs and clarifies several open questions.
View all publications

Related News

05/15/13 Pharma Cos. Smell Victory In Push For Drug-Tracking System, Law360
Life Sciences partner Stephen Paul Mahinka is quoted.
04/23/13 FDA's OxyContin Ruling May Spur New Battles Over Generics, Law360
FDA partner Rebecca Dandeker comments on the recent FDA ruling to block generic versions of the painkiller OxyContin.
View all news

Compliance Resources

New Resource: Health Industry Transparency Compliance Resource Center

Healthcare Compliance Brochure

FDA Food Safety Modernization Act

Morgan Lewis understands the challenges facing the health industry in this era of increasing governmental regulation and enforcement. The pace of new regulations and statutes affecting regulatory obligations, reimbursement, and coverage creates new opportunities and challenges for manufacturers and suppliers, providers, payors, and patients. Health industry sectors are becoming increasingly interconnected and the laws governing them are closely linked. Providing effective and efficient legal services to the health industry requires integrated legal advice that addresses different regulatory structures and emerging industry developments.

Morgan Lewis has assembled a group of nationally recognized FDA and healthcare attorneys and professionals who take a collaborative and integrated approach to the representation of health industry clients in matters involving FDA, health regulatory, reimbursement, finance, policy, corporate, privacy/security, compliance, and government enforcement matters. On complex matters, our integrated approach gives clients peace of mind that their issues have been examined from every critical angle.